Antisense approaches enter the clinic.
Khuri
F R
FR
Kurie
J M
JM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016373:DNA, Antisense / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use; D019908:Proto-Oncogene Proteins c-raf / Q000037:antagonists & inhibitors / Q000235:genetics; D013873:Thionucleotides / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016373:DNA, Antisense; D004791:Enzyme Inhibitors; D020319:Oligodeoxyribonucleotides, Antisense; D013873:Thionucleotides; C099587:ISIS 5132; D019908:Proto-Oncogene Proteins c-raf